tretinoin

(redirected from Retin-A Micro)
Also found in: Medical.

tret·i·noin

 (trĕt′ĭ-noin′)
n.
An isomer of retinoic acid used topically to treat acne and to mitigate fine facial wrinkling and orally to treat one form of leukemia.

tretinoin

(trəˈtɪnəʊɪn)
n
(Pharmacology) pharmacol a synthetic form of vitamin A used as a drug to treat certain skin conditions and a type of leukemia

tre•tin•o•in

(trəˈtɪn oʊ ɪn)
n.
a drug chemically related to vitamin A, used as a topical ointment to treat skin disorders, esp. acne.
[1960–65; t(ri-) + retino- (< Greek rhētinē resin) + -in1]
Translations

tretinoin

n tretinoína
References in periodicals archive ?
The 20-year agreement takes effect the first quarter of 2016 and will initially cover Valeants dermatology products including, most notably, Jublia, Luzu, Solodyn, Retin-A Micro Gel 0.
M2 EQUITYBITES-February 3, 2014-Valeant Pharmaceuticals International Inc secures FDA's approval of Retin-A Micro Microsphere 0.
M2 PHARMA-February 3, 2014-Valeant Pharmaceuticals International Inc secures FDA's approval of Retin-A Micro Microsphere 0.
The acquisition of Ortho gives Valeant ownership of such brands as Retin-A Micro acne treatment and Renova, a wrinkle-reducer.
Disclosures: The study was sponsored by Johnson & Johnson, whose Ortho Dermatologics division markets the Retin-A Micro Pump.
A national survey conducted on behalf of Retin-A Micro Pump has found that acne can negatively impact many aspects of an adult's life--professional, academic, physical and social--and a lack of knowledge may be preventing or hindering appropriate treatment options.
Upon completion of the transaction, Valeant is entitled to prescription brands RETIN-A MICRO, ERTACZO and RENOVA.
They can also access other skin care features and receive a $5 gift certificate good toward the purchase of Ortho's Retin-A Micro, when prescribed by a physician.
The Company recorded a gain on the sale of its interests in royalties from sales of Retin-A Micro and Carac of $23,421,000 in the first quarter of 2006.
First quarter royalties on sales of Carac and Retin-A Micro grew by 18% and 7%, respectively.
Fourth quarter royalties on sales of Retin-A Micro and Carac grew by 10% and 18%, respectively.
Quantum, recently named "Agency of the Year" by DTC Perspectives magazine, received the Silver Award in the "Best Branded Television" and "Best Radio Campaign" categories for its work on consumer campaigns for Crestor, a cholesterol treatment, and Retin-A Micro, a topical acne treatment, respectively.